Michael Greve: Longevity Pioneer
Internet entrepreneur Michael Greve has gone from overweight hacker to longevity trailblazer with his Forever Healthy Foundation. See what he's already doing today to live longer.
If you can somehow manage to stay reasonably fit for the next - say five, ten, fifteen - years: Do it! Really. It could be that by then, at least half of today's causes of death will be obsolete.
This may be the story of your salvation from cancer, heart attack, stroke, diabetes, and Alzheimer's, the story of your first half-marathon at one hundred and ten, your study of literature at ninety, and your Harley-Davidson at eighty.
The story is remarkably close to a happy ending.
Before we get started with the story of how your life will be saved, it's good to know where this story began and where it currently stands.
It all started with Michael Greve being very rich and very unhealthy.
He had become rich by popularizing the internet in Germany: He founded web.de with his brother in the early 1990s, and the two built the company into Germany's flagship digital start-up, selling it for a nine-figure sum in 2006.
Greve had become unhealthy because for more than twenty years he conformed to every lifestyle cliché of a hacker: pizza, red wine, cola, three packs of cigarettes a day, a movement radius of desk-bed-refrigerator, 20 kilos overweight.
Greve sees aging as a treatable disease, not an unavoidable fate.
After selling web.de, Greve was so rich that a life awaited him in which the most difficult decisions were between helicopter snowboarding in Alaska or surfing in Bali. Or what kind of internet start-up he'd like to get into next. (Three of the startups Greve fancied became unicorns: Babbel, Staffbase, Mambu - he's still involved today).
Michael Greve thought to himself: It would be stupid to kick the bucket now.
He started to look into nutrition, gave up coke, pizza, and red wine, lost 20 kilos, gave up smoking, gained the 20 kilos back, and lost them again. After a total of three years, his body was ready for a life that wouldn't have to be boring for decades.
Greve thought to himself: to kick the bucket now would be even stupider.
Then he made the decision that changed his life, and may soon change yours: To not end up as the richest man in the graveyard. Michael Greve decided to take such a serious approach to health that he began to study the field of longevity, the science of extending the healthy human lifespan. He plowed through studies and began to get involved, as actively as only a person with a nine or ten-figure bank account can.
Five years ago, he donated the first ten million to the SENS Research Foundation in Silicon Valley, an authority on longevity research. In the same year, 2016, Greve founded the Forever Healthy Foundation, based in the former web.de offices.
Status Quo - Michael Greve 2021: 57 years old, biohacker and investor
© Sebastian Arlt
Where things currently stand in September 2021
Forever Healthy has long been globally active, the language of the foundation is English, and the most recently hired employees are based in Istanbul and New York. From Karlsruhe, Greve and a small team currently manage 14 startups that have emerged from particularly promising research projects.
In collaboration with the SENS Research Foundation, he organizes an annual conference at which the industry's renowned scientists and opinion leaders meet ("Undoing Aging," Berlin, next date: May 2022). As a global networker, he ensures that longevity researchers in San Francisco, London, Bangkok, and Basel don't dabble in the same topics in an uncoordinated way, but build on each other's findings (a bit like Wings for Life does in spinal cord research).
With his own team, he produces scientific papers that can be thought of as a screenshot of current world knowledge on a topic - each paper based on about 2000 abstracts and 150 studies. He publishes them in a database on his website, freely accessible to anyone at any time, comprehensibly transformed into practical advice, for example things like fisetin and EDTA. We will come back to that.
He has turned himself into the leading global figure of a new approach to longevity: he talks about rejuvenation, the preservation and restoration of youth. He talks about viewing the process of aging as a treatable disease, not an inescapable fate. All this not with the goal of eternal life, but of prolonging the healthy life span as much as possible.
To give you an idea of the avalanche Greve has unleashed in the past five years: One of his 14 startups has reached the point where it can dissolve tumors by injection. Another one can repair broken arteries.
It already works in animals.
If you were a mouse or rabbit, you would be reasonably safe from cancer and atherosclerosis by now.
Whether we abolish cancer, heart attacks, and dementia is no longer a question of if. It is a question of when.
Michael Greve is 57, which you could hardly tell by looking at him.
The hacker has become a biohacker - morning routine, gratitude journal, yoga practice, sleep tracking, and 30 supplements a day (that complement an already hand-picked diet). The works. His goal: being as fit as a thirty-year-old at seventy. Not a desire, the goal.
Greve also says: "Whether we succeed in abolishing age-related diseases such as cancer, heart attacks, and dementia is now no longer a question of if. It's a question of when."
Okay. So ... when will that be?
"Some things will probably be ready in five, ten, fifteen years. My ambition is clear: I want to be able to use what we find out for myself, for my life."
Take a moment to let what follows sink in, it may sound like an admission, but it is, if you listen more closely, a promise: "My life span, that's the time horizon."
Now, this has to be said as clearly as it can be said: the man is not a crazed billionaire who wants to buy eternal life and drink the blood of virgins sacrificed on a full moon during his lunch break. The man is an extremely successful entrepreneur who has learned to think in terms of visions, goals, strategies and results, in terms of weighing risks, and who uses this entrepreneurial know-how to drive a very young, very experimental field of science. With the power of his money, of course, but even more essentially as a kind of manager, coordinator, mastermind. "Scientists are often bad entrepreneurs," he says. "We don't just fund the startups. Most importantly, we are their mentors."
At the least, Michael Greve is a highly motivated and potent patron of very specific medical research and a moderately patient entrepreneur when it comes to putting it into practice.
At best, he is a godsend of historic proportions for humanity. So, this is where we are right now.
Michael Greve 2041: 77 years old, thanks to research as fit as he was at 30
© changemyface.com
What comes next? And how long will it take?
What is currently normal is not necessarily great.
Worldwide around 150,000 people die every day: 50,000 from accidents, violence, wars, things like that. 100,000 from diseases like diabetes, cancer, Alzheimer's, and heart attacks. You could simplify it and say: 100,000 people die every day from the worst disease in the world, namely aging. Because cells go haywire, because too much stuff that doesn't belong there has accumulated in the body over decades, because something is crumbling or clogged or stuck together, wear and tear at all levels. At some point, all of this manifests in one of these diseases, years of suffering, huge social costs, family dramas, death.
We humans have lived with this for a few million years, we humans have died with this for a few million years.
We have become accustomed to that.
But does it have to stay that way?
No, says Michael Greve. He speaks of his grandmother, who took ten years to perish from dementia. All in front of the family. "At some point, she no longer recognized anyone, but my brother. Is something like that supposed to be normal? We're supposed to accept something like that?"
I don't care. It's my money, I'm not accountable to anyone.
We're not talking about "someday".
"What we're doing now," he says, "is getting to the bottom of the whole thing. Where does cancer start, where does Alzheimer's start? Where is the root? And more importantly, what can we do about it? I'm only interested in research that results in action. So in working with our startups and at our conference, we don't talk about worms and regulatory stuff. We're not talking about someday. We're talking about humans, we're talking about therapy, and we're talking about now. We're talking about reality, not science fiction."
We actually now know quite a bit about the career of a common age-related disease. Each of the great killers of humanity has its own origin, its root cause. In total there are about 30 to 40 processes that cause us to become old and sick, they facilitate and accelerate each other. The deadly game of biological aging is teamwork.
But, and this is the really good news: These root causes can be isolated. Each can be researched separately and each can be treated separately.
WHAT IS HAPPENING OUT THERE RIGHT NOW: SENESCENT CELLS
We are made up of about 100 trillion cells. Each of them will break down, some every few days, others every few years. A broken cell is destroyed, eaten, recycled, replaced by a new one. An ingenious system, but not entirely flawless. Senescent cells are cells that are damaged and should be removed. But for some reason, they hang around. Zombies. It doesn't matter as long as there are a few. But over the decades, more and more of them accumulate. Taking space away from fresh cells and producing toxins.
More senescent cells mean more cell toxins, more cell damage, more aging, more disease.
What can we currently do about senescent cells?
Nothing. Except maybe take fisetin once a month, 1.5 grams the first day, 1.5 grams the second day. "That's pretty likely to work," Greve says. "And it's risk-free, the evidence from studies is clear. I personally do it. Costs 30 euros a month, you can get fisetin anywhere, anyone can do it. If we laugh about fisetin five years from now, nothing bad will have happened. If we find out in five years that fisetin works well, I'll have benefited from it for five years longer."
How quickly will we really get a handle on the senescent cell problem?
"There are many people working on that, not just us (Note: New York State startup FoxBio is one of the 14 in Michael Greve's portfolio). Whether we succeed or another company succeeds, I don't care."
What you can't imagine as a layperson is how medicine works as a business.
We don't need to beat around the bush, medicine is an industry: money attracts clever minds, more money attracts cleverer minds, it's simply a battle for brainpower - even saving lives obeys the laws of the economy.
What is the entrepreneurial approach to a start-up that removes senescent cells from the body or cancer from the world?
Basic research is - surprise! - the much smaller part. "It can take just a few million to get to the point where you can think about creating a startup." And the startup simply translates theory into practice? Take a test tube, multiply it ten million times and send the drug out to pharmacies?
You invest hundreds of millions. And for the next ten or fifteen years, you're just a phone call away from total failure.
If that were the case, we would all be taking three pills a day by now, and cancer, Alzheimer's, diabetes, and stroke would all be a thing of the past.
It's not like that.
Every startup in the rejuvenation field is something of an expedition: you have a pretty clear idea of your goal, but you only have a rough idea of where the road will lead, no idea what obstacles await you along the way. Maybe there is no road to the goal at all. The only thing that's sure is that anyone who doesn't start with 200, 300, 400 million euros under his belt doesn't need to start at all.
What Greve is doing is radical from the point of view of a conventional investor. "I know the risks, of course, but I don't care. We go in when the science behind it is compelling to us. We invest, we incorporate, we put a team together. I can do it that way because it's my money. I'm not accountable to anyone. When it's gone, it's gone. My thing."
WHAT IS HAPPENING OUT THERE RIGHT NOW: CANCER
There are people whose immune system kills cancer cells. They are immune to cancer. London-based startup Lift BioSciences is harnessing these people's enigmatic ability. "We're sort of harvesting the immune system of these people," Greve says.
"We multiply it in a bioreactor and make it injectable. In animal studies, it already looks like this: Mice with thumb-sized tumors get such an injection. Forty-eight hours later, the cancer is gone."
... gone? Cancer?
"Yes. Gone. Solid tumors. Not leukemia, it doesn't work there, but tumors."
How long does it take for the cancer shot to make its way from the mouse to our hospitals?
"It depends on the clinical trials. I expect five, seven, 10 years."
And how realistic ...?
"... Can't say yet. It really doesn't look bad. But for sure, with all these companies, you only know one thing anyway: if no one does it, the probability will always remain zero."
Game over, anytime.
Let's stick with the image of the expedition. No matter how well a drug works in theory, in the test tube, and in animal testing, the last and hardest part of the journey consists of four stages. There are four clinical phases to complete to get from the perfect animal trial all the way to the pharmacy.
Officially, phase 1 is just looking to see if the drug will harm humans. Small group, mostly healthy people, extensive monitoring. "Unofficially, of course, you pay attention to whether the drug has the effect you expect, otherwise you don't continue at all." If everything works out perfectly: on to phase 2, first application in potential patients, evaluating efficacy and safety, extensive monitoring. If one of the participants develops sleep disturbances, notices an allergy or a few hairs fall out, the thing stops until you can rule out that it has to do with the drug. Phase 2 over, everything still perfect? Then phase 3: a clinical trial with around 1000 participants, usually lasting two years and taking place in various hospitals. In phase 4, the new drug, freshly approved, is observed in clinical practice.
During the whole process - yes, even after approval - any day a result can come from some lab, from some hospital, that kills the whole story, game over. You're literally one phone call away from total failure for five, ten, fifteen years.
If nobody calls, eventually, you go into production. That then means: no longer producing tiny quantities for studies in the lab, but marketable quantities in a large facility, again millions and millions of additional costs, huge technical, organizational, personnel expenses.
But by then, the world might already look very different than it did before.
WHAT IS HAPPENING OUT THERE RIGHT NOW: HEART ATTACKS, STROKES
"When cholesterol oxidizes in the walls of our blood vessels, it creates something that our system recognizes as a foreign body. The immune system becomes active, the so-called macrophages kick in and send this oxidized cholesterol to their internal waste disposal facility, the lysosomes. There, toxins, protein residues and all the other garbage we need to get rid of are broken down. Unfortunately, oxidized cholesterol cannot be broken down in the lysosome of our cells. We don't have an enzyme for that. That sucks."
"Because what happens then: The immune cells take up more and more of this cholesterol, the lysosomes keep expanding and expanding, plaque builds up. The plaque accumulates in the artery wall, it eventually ruptures, the body detects an injury, blood coagulates, a clot of blood and plaque forms, the artery gets blocked. That's what we call a heart attack. Or stroke, if the clot blocks a vessel in the brain."
Underdog Pharmaceuticals in Mountain View, California, is working to eliminate heart attacks and strokes like this:
"We've developed a special sugar called cyclodextrin. It goes through the blood vessels into the artery wall, into the macrophages, into the lysosome, grabs the oxidized cholesterol, transports it out of the lysosome, out of the macrophage, out of the body. Just like you detoxify common toxins. The sugar removes the plaque, and it's excreted like any other toxin."
So, I swallow a sugar pill and excrete the plaque from my arteries? Just like that? Via, uh, stool and urine?
"That's the plan."
And when will that ...?
"It's working so well in mice that we can go to phase 1 next year, maybe the year after."
What's the likelihood that what works in mice will work in humans?
"In this case, pretty good, because mouse plaque and human plaque are very similar. But how far down the road we really are, we can't say yet, that's just the way it is in bioscience, the craziest things pop up along the way: Cyclodextrin, for example, in extremely high doses, causes hearing loss under certain circumstances. No one knows why. We're working on that now. Then we'll move on."
Greve's goal with cyclodextrin is very specific: one sugar pill a day as protection against heart attacks and strokes, retail price no more than ten dollars a month. "Everything we develop should be affordable for everyone in the world," he says. "That's extremely important to me. These new drugs don't have to cost thousands of dollars. At ten dollars a month, maybe only one or two in poorer countries, we will still make more than enough."
"This is going to be the biggest industry in the world."
Greve has always been and will always be a businessman. If things go well, for the next hundred years. He behaves like a philanthropist, but he thinks, feels, and talks like an entrepreneur.
"Rejuvenation will become the biggest industry in the world. I'm one hundred percent convinced of that. Look at this," he picks up his iPhone from the table, "this is the most valuable brand in the world right now. Phones. You don't have to think twice about what's worth more: a phone or a life without cancer, without stroke, without dementia."
Rejuvenation is something like the digital revolution, only much, much bigger: it will be the most fundamental change in our entire history.
Greve knows what it means to be a pioneer. "I've seen the transformation from no PC to PC, the emergence of the internet, of mobile, of cloud services, of all these things that have completely changed our world. And this is going to be just like the digital revolution, only much, much bigger. Rejuvenation is going to be the most fundamental change we've ever seen in our entire history. To realize that it's also going to be the biggest business in history, all it takes is a bit of math: four billion people over forty, ten dollars a month, makes $480 billion year after year. That's a five trillion-dollar company. That is the magnitude of it, and we're only talking about a single root cause."
WHAT IS HAPPENING OUT THERE RIGHT NOW: MITOCHONDRIA
We have mitochondria by the tens of thousands in every single cell. They are known as "cell power plants," and rightly so because they produce ATP, adenosine triphosphate, our life fuel. Human gasoline. We produce and consume a lot of it, a 70-kilo person about 35 kilos a day, and we depend on our mitochondria being in top shape: If they take a five-second break, we're dead.
Mitochondria get a little sloppy with age. That's not good news, because it makes our immune system sloppier too; overall, we get weaker, tired, sicker. Researchers are pretty sure that healthy people have healthy mitochondria, listless ones have listless mitochondria, and sick ones have sick mitochondria.
Cellvie is one of 14 startups from Greve's portfolio; the company, which has offices in Zurich, Boston, Massachusetts, and Houston, Texas, is working on something called Therapeutic Mitochondrial Transfer.
Therapeutic Mitochondrial Transfer is actually what it sounds like: the transplant of mitochondria.
Take a few of a 25-year-old athlete's power plants, multiply them in a bioreactor, and inject them into, say, a 70-year-old who's in intensive care after major surgery.
Cellvie has reached the point where mitochondria can not only be injected, but also inhaled. They are absorbed through the lungs, with no immune reaction, no rejection, no matter the donor, no matter the recipient.
There will be a mitochondrial spray. It will improve and save the lives of millions of people with lung diseases.
We will transfer life energy, health, and vitality from one person to another. We will facilitate all kinds of organ transplants with the help of mitochondria. And, we are already saving lives.
"We have reached the point where we can apply the technology in humans," says Greve. "We are using it in children who are born with a certain defect in the heart muscle. Until recently, 80 percent of these children died. We injected mitochondria from the mother into the heart muscle of the newborn. That's how we got the mortality down to 30 percent."
How old are we actually going to get?
"No idea," says Greve. "We don't know. Something around 120, 150, 180 maybe. If you don't take care of a classic car, it'll be broken after 50,000 miles. If you put it in the garage, maintain it, change the oil, keep an eye on the rust ... then how long does it run for? 300,000 kilometers? 500,000?"
How long do you want to live?
"I don't ask myself that question. It's about quality, not quantity. I want to be able to do anything I want as long as I live, snowboarding, working, whatever. I don't want to spend ten years at the end of my life suffering from a horrible disease that could have been prevented. And I want to live in a world where what's possible for me is possible for everyone."
WHAT IS HAPPENING OUT THERE RIGHT NOW: CALCIFICATION
We already touched on the topic of plaque earlier, with oxidized cholesterol and the miracle sugar that Underdog Pharmaceuticals is working on. That was about the so-called soft plaque. But there is also hard plaque, calcification, bone material that has been deposited in the wrong place. In arteries, in the capillary system, the kidneys, the lungs, the heart muscle. Vessels become brittle, fragile, and break down.
"There's been a way to remove calcification for quite a long time. It's called EDTA, it's a special protein, costs hardly anything, maybe that's why it's not used much in medicine, who knows.
Since the last century, EDTA was used to treat lead poisoning in workers in battery factories - and at some point, it was discovered that the workers got fewer cardiovascular diseases than other people. It was the EDTA that was responsible, they figured. Today there are EDTA infusions, routine, I do them too, but they have a downside: it's a matter of chance whether the injected EDTA reaches the place in the body where this calcium plaque has formed, or whether it ends up somewhere else in the body."
Elastrin Therapeutics, based in South Carolina, USA, has developed a technique to deliver EDTA to the calcified plaque with pinpoint accuracy: "We load nanoparticles with EDTA, equip these nanoparticles to dock exactly at those sites in our connective tissue where elastin fibers are broken. In other words, exactly where calcification occurs. They track it down, and that's where they release the EDTA. And while we're at it, we send out more of these nanoparticles with another active ingredient, PGG, which directly repairs the broken elastin. This means that we can not only decalcify arteries, but also heal them. In rabbits, we've gotten to the point where we can fix aneurysms with this technique."
Aneurysms are weaknesses in arterial walls that take the lives of more than 500,000 people a year worldwide from one minute to the next, completely without warning.
What does a world look like in which we all live to be 120, 150, 180 years old?
What happens if Greve and his Forever Healthy Foundation actually save your life someday, and 20,000, 30,000, 70,000, eventually 100,000 more people, day after day? Because his startups have found a cure for cancer, for heart attacks, for dementia? Because every morning we take a shot of fresh mitochondria instead of coffee - and not only get a quick caffeine kick, but a turboboost to our youthfulness and vitality?
That means less suffering, yes, immensely reduced costs to the health care system, yes, and you can get some funny ideas, too: Rafael Nadal wins the tournament in Paris 75 times, 80-year-olds storm the universities, marathons need 120-plus age groups, and 90-year-olds put a Harley-Davidson in their garage because a midlife crisis has gripped them.
But seriously, what will happen to our society? To our planet? Will we all starve to death because we no longer die? There are no more than 149 million square kilometers of land on the planet Earth, and those who die … make room for others? Will we eventually have too little space?
These are questions that touch on Michael Greve's mission in life: He could spend his days snowboarding and surfing, he could get his pilot's license, grow a few IT unicorns in between, watch his bank account like we watch the gauge on the gas pump when we fill up. He could throw parties every night and organize a kind of personal experiment in eternal youth with the best scientists in the world.
But that is of no interest to him. His personal health project has become his mission.
Rafael Nadal wins the tournament in Paris 75 times, 80-year-olds storm the universities, marathons need 120-plus age groups.
When asked the above questions, he replies, "What disease are we not supposed to cure? Should we do nothing about cancer? Nothing about stroke? Nothing about dementia? What shall we leave out, tell me!"
But what does that do to us as humanity if there are more and more of us? Do cities just sprawl into mega-zillion-monsters? Do we wage wars over living space? Will the planet one day just throw us off because it can't breathe anymore?
I feel insanely unprogressive when I ask these questions. But are they unjustified?
Michael Greve thinks they are unwarranted because he questions the perspective from which they come. It will likely become part of his mission to change not only our perspective on health and life expectancy, but also our perspective on the future, because there may be a lot more of that pretty soon.
Greve can do future, Greve loves all things future, he has proven that as a digital revolutionary, and he is a completely untalented worrywart. He sees opportunities where others see threats, otherwise, he never would have created all those unicorns.
Greve also wants to change our perspective on the future, because there may be a lot more of it pretty soon.
"Our world is changing radically, and it's happening exponentially fast, whether we like it or not", he says. "Space exploration, artificial intelligence, robotics, self-driving cars, there will be superfast Internet at every point on the planet. You'll be able to work from the North Pole, like you do today in your home office. Take nanotechnology, most people don't even realize what that will mean. There will be molecular assembling, 3D printers, but on the atomic level. Nobody knows, and some of it is already here. Our world will be a different one, regardless of whether we contribute to the change or like that change. The change will be radical, and it will mean one thing above all: lots of huge opportunities."
WHAT IS HAPPENING OUT THERE RIGHT NOW: WRINKLES, HIGH BLOOD PRESSURE
The fact that our 100 trillion cells are not just a flabby mass, but a neatly structured, fairly solid body, is thanks to what is known as the extracellular matrix. It holds each cell in its intended place. Essentially, this three-dimensional, wonderfully flexible, and supple matrix consists of collagen.
Flexibility and suppleness of the matrix are lost with age, this is also what makes our skin look older. The reason for wrinkles and other hardening and stiffening of the matrix is sugar, which combines with collagen to form so-called advanced glycation end products (AGEs). We can slow down this process through our lifestyle choices, but we can't stop it. (And even less reverse it, not even with creams costing 400 euros for 30 grams, unfortunately.)
Of course, we do not only age externally. Our vessels also form AGEs, we get age-related high blood pressure, more plaque, more arterial lesions, the rest: see above.
Our bodies can't break up these AGEs, and if we don't get that under control, sooner or later, we'll die from the very process that's responsible for our wrinkles. That's what Revel Pharmaceuticals, based in San Francisco, wants to change. (And, yes, because you can't get the question out of your mind: you're right, breaking up AGEs would be the anti-wrinkle breakthrough. If Revel succeeds, our skin at ninety really will look like it did at 25.)
When scientists tried to isolate AGEs for research - not from living people, for understandable reasons - they made a startling discovery: cadavers don't have AGEs.
In fact, once we're dead, these nasty sugar-protein compounds are broken down by enzymes, which in turn are produced by special bacteria.
Revel can cultivate these bacteria and harvest the enzymes produced, in a kind of beneficial bacteria farming.
Today, AGEs can be produced industrially (funding for the corresponding research: Forever Healthy Foundation). However, in the beginning, to isolate AGEs, without having to carve out pieces of meat from living humans, they used, hold on now:
Chicken soup. Scientists extracted the stuff that makes us old and wrinkled by boiling chicken bones. Maybe we'll all live to be 150 because someone got the idea to feed bacteria with chicken soup.
Just you try and say evolution doesn’t have a sense of humor.
Closing remarks: Michael Greve
"Let's just say hypothetically that you live for 150 years. You'll have several careers, you'll live several professional lives, maybe you'll be a doctor for fifty years and a gardener for fifty years? We'll all be healthy longer, productive longer, we'll all be in good shape longer. Let's imagine what that translates into: engineers, researchers, managers, artists who are eighty, ninety, a hundred, with all their life experience, but with the energy of a thirty-year-old! How wonderful is that?"
"I'm absolutely convinced: the way we look at the Middle Ages today - manure sloshing down the gutter, people smelly and dying at 35 - that is how people will look at our time. People won't be able to imagine all this anymore. They will say of us: 'They all perished from these terrible diseases, from heart attacks, strokes, Alzheimer's disease. They polluted the water and air and stuffed themselves with toxic things. They treated the planet like snotty teenagers treat their bedroom.' That's what the people of the future will say about us. They will shake their heads and be glad that they live in civilized times, on a healthy planet.
That we get there, as quickly as possible, is something I would like to contribute to. Of course, we must immediately start to keep our home clean, that is clear, whether there is rejuvenation or not. We need sustainable, clean agriculture, exclusively renewable energy, rigorous environmental protection, ideally all of this right now. We will have to rethink the issue of income. But we're going to have to do that anyway, even without rejuvenation."
“What I know 100% is that we humans can do all this. That we can develop a society and create a world where growing old is fun and where it’s possible for everyone.”
